Alex Delaney-Gesing, Senior Editor

Andrew G. Iwach, MD, shares a few key highlights from his presentation regarding trend challenges of glaucoma.

Oluwatosin U. Smith, MD, speaks shares the highlights of her presentation exploring remote monitoring of glaucoma and the future of virtual care on the whole.

Ranya Habash, MD, shares a sneek peek of her New Horizions keynote speech on "The future of eye care: science fiction to science fact," during the 2022 Glaucoma 360 meeting.

The actress and singer-songwriter will serves as the brand ambassador for OptiLight, a new dry eye disease treatment.

A new paper looks to debunk 10 contact lens notions long-held by eyecare practitioners.

The FDA announced approval of the first generic version of Restasis (cyclosporine ophthalmic emulsion) 0.05% eye drops Thursday.

The optical technology company announced two updates to their product line.

Positive one-year results of Genentech’s phase III trials analyzing faricimab for treatment of wet AMD and DME were released today.

Alcon has launched the latest addition to its European dry eye products portfolio: Systane Complete Preservative-Free Lubricant Eye Drop, available in an easy-to-use, multi-dose bottle, the company announced last week.

The 25th annual event was originally scheduled for January 16-19.

The FDA has approved XIPERE for the treatment of macular edema associated with uveitis